Kevin B Gurney

Title: Kevin B Gurney: Innovator in Virus Neutralization Assays

Introduction

Kevin B Gurney is an accomplished inventor based in Morristown, NJ (US). He holds a patent that significantly advances the field of virology. His work focuses on improving the efficiency of virus neutralization assays, which are crucial for understanding viral infections.

Latest Patents

Gurney's notable patent is titled "Virus neutralization assay utilizing imaging cytometry." This invention describes a virus reduction neutralization test (VRNT) that serves as a rapid, high-throughput alternative to traditional low-throughput and labor-intensive neutralization assays. The VRNT employs imaging cytometry to count virus-infected cells approximately one day post-infection. This innovation eliminates the lengthy wait times associated with other assays, thereby reducing overall assay time and increasing throughput by at least 15-fold.

Career Highlights

Throughout his career, Gurney has made significant contributions to the pharmaceutical industry. He has worked with prominent companies such as Merck Sharp & Dohme LLC and Merck Sharp + Dohme Corp. His expertise in virology and assay development has positioned him as a valuable asset in the field.

Collaborations

Gurney has collaborated with notable colleagues, including Joseph M Antonello and Leah A Bogardus. These partnerships have further enhanced his research and development efforts in the area of virus neutralization.

Conclusion

Kevin B Gurney's innovative work in virus neutralization assays exemplifies the impact of scientific advancements in virology. His contributions continue to influence the efficiency of viral testing methods, showcasing the importance of innovation in healthcare.